| 产品名称: |
M40 |
| 规格或纯度: |
Moligand™ |
| 作用类型: |
拮抗剂 |
| 作用机制: |
GAL 1 受体拮抗剂;GAL 2 受体拮抗剂;GAL 3 受体拮抗剂 |
| 靶点: |
Neuropeptide Y Receptor |
| 体内研究: |
M40 (0.1-1 nmol, intracisternal injection, single dose) blocks selectively the central cardiovascular responses induced by galanin-(1–15) in Sprague-Dawley rats models, according to the recognization of galanin receptor in N-terminus. M40 (2-8 nmol, intraventricular or intrahippocampal, single dose) exhibits antagonist efficacy against galanin on memory tasks in sprague-dawley rats models, exhibits potency in alleviating the cognitive deficits associated with Alzheimer's disease. |
| 参考文献: |
1. Bartfai T, et al. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11287-91. |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.505 ml |
2.524 ml |
5.047 ml |
| 5 mM |
0.101 ml |
0.505 ml |
1.009 ml |
| 10 mM |
0.05 ml |
0.252 ml |
0.505 ml |
| 50 mM |
0.01 ml |
0.05 ml |
0.101 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |